It is provided new chemical entities allowing simultaneous diagnosis and treatment of cancers. More specifically, it is provided a theranostic compound consisting of a stabilized peptide ligand (agonists and antagonists) for the kinin B1 receptors (B1R) conjugated to specific radionuclides (e.g. 64Cu) suitable for dual imaging/radiotherapy applications.
提供了可同时诊断和治疗癌症的新
化学实体。更具体地说,本发明提供了一种疗法化合物,它由稳定的激肽 B1 受体(B1R)
多肽配体(激动剂和拮抗剂)与特定放射性核素(如 64Cu)共轭组成,适用于双重成像/放射治疗应用。